glp-1 or semaglutide Another Weight-Loss Trial Win for Weekly Drug GLP-1 for Weight Loss: How

Wegovy treatment typically begins with a dosage of 0.25 mg injected under the skin once a week

This kind of pain may be brought on by inflammation, irritation, or nerve compression

Sabado et al., 2017)

Serotonin beyond the blood-brain barrier Due to its size, serotonin (5-HT) faces difficulty crossing the blood-brain barrier, and therefore its functions in the central nervous system and peripheral tissues are generally considered separate [31]

June 12th, 2025: EMA Links Semaglutide to Rare Vision Disorder The European Medicines Agency (EMA) has formally acknowledged a potential link between semaglutide, the key ingredient in Ozempic, Wegovy, and Rybelsus, and a rare but serious eye condition known as non-arteritic anterior ischemic optic neuropathy (NAION)